Individualizing drug therapy in patients with diabetes and chronic kidney disease

MacCallum L . Optimal medication dosing in patients with diabetes mellitus and chronic kidney disease. Can J Diabetes 2014;38:334-43.

Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes 2013;37. Appendix 7, Sick day medication list; p. S209.

MacCallum L . Guidebook for pharmacists on diabetes management: helping patients reach treatment goals. Toronto (ON): Banting & Best Diabetes Centre, University of Toronto; 2014.

Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes 2013;37. Appendix 6, Therapeutic considerations for renal impairment; p. S207-8.

Dapagliflozin monograph. In: Compendium of Pharmaceuticals and Specialties, 2014. Ottawa (ON): Canadian Pharmacists Association; 2014. Available: https://www.e-therapeutics.ca (accessed August 19, 2015).

Empagliflozin monograph. In: Compendium of Pharmaceuticals and Specialties, 2015. Ottawa (ON): Canadian Pharmacists Association; 2015. Available: https://www.e-therapeutics.ca (accessed August 19, 2015).

Alogliptin monograph. In: Drug Product Database, 2013. Ottawa (ON): Health Canada; 2013. Available: http://www.hc-sc.gc.ca (accessed August 19, 2015).

Albiglutide monograph. In: Drug Product Database, 2015. Ottawa (ON): Health Canada; 2015. Available: http://www.hc-sc.gc.ca (accessed August 19, 2015).